In a landmark trial, a cocktail of immunotherapy medications harnessed patients’ immune systems to kill their own cancer cells and prompted “a positive trend in survival”, according to researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS foundation trust. The Guardian
See also:
- Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers Institute of Cancer Research
No comments:
Post a Comment